107 related articles for article (PubMed ID: 2225561)
21. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
22. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakamoto S; Yoshimura N
Transplant Proc; 2009; 41(1):446-9. PubMed ID: 19249577
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy].
Kikuchi M; Saeki T; Ito S; In H; Saito T; Ueno M; Sato T; Suzuki S; Nakano M; Ozawa T
Ryumachi; 1993 Jun; 33(3):215-22. PubMed ID: 8346463
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal immunoglobulin deposition disease associated with membranous features.
Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
Murphy BF; Fairley KF; Kincaid-Smith PS
Clin Nephrol; 1988 Oct; 30(4):175-81. PubMed ID: 3214963
[TBL] [Abstract][Full Text] [Related]
26. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
27. [Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis].
Baba N; Nomura T; Sakemi T; Uchida M; Watanabe T
Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):629-34. PubMed ID: 1920943
[TBL] [Abstract][Full Text] [Related]
28. Effect of anti-schistosomal treatment on schistosomal-specific nephropathy.
Sobh MA; Moustafa FE; Sally SM; Deelder AM; Ghoniem MA
Nephrol Dial Transplant; 1988; 3(6):744-51. PubMed ID: 3147416
[TBL] [Abstract][Full Text] [Related]
29. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
30. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
31. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
32. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.
Hoxha E; Harendza S; Zahner G; Panzer U; Steinmetz O; Fechner K; Helmchen U; Stahl RA
Nephrol Dial Transplant; 2011 Aug; 26(8):2526-32. PubMed ID: 21633097
[TBL] [Abstract][Full Text] [Related]
33. Membranous glomerulopathy following kidney transplantation. Association with renal vein thrombosis in two of nine cases.
First MR; Mendoza N; Maryniak RK; Weiss MA
Transplantation; 1984 Dec; 38(6):603-7. PubMed ID: 6390820
[TBL] [Abstract][Full Text] [Related]
34. Recurrent and de novo membranous glomerulonephritis in renal cadaver allotransplants.
Briner J; Binswanger U; Largiadèr F
Clin Nephrol; 1980 Apr; 13(4):189-96. PubMed ID: 6991185
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of steroid therapy in different stages of membranous nephropathy.
Fuiano G; Stanziale P; Balletta M; Sepe V; Marinelli G; Comi N; Esposito A; Andreucci VE
Nephrol Dial Transplant; 1989; 4(12):1022-9. PubMed ID: 2517322
[TBL] [Abstract][Full Text] [Related]
36. [Clinical pathology of the glomerulus--from phenomenon to entity. The minimal glomerular lesion].
Sorger K
Verh Dtsch Ges Pathol; 1989; 73():105-11. PubMed ID: 2482593
[TBL] [Abstract][Full Text] [Related]
37. [Clinical aspects of cystinuria and its treatment by thiola (author's transl)].
Zechner O; Latal D; Gründig E; Müller M
Wien Klin Wochenschr; 1976 Feb; 88(3):101-5. PubMed ID: 960706
[TBL] [Abstract][Full Text] [Related]
38. Outcome and treatment of bucillamine-induced nephropathy.
Hoshino J; Ubara Y; Hara S; Suwabe T; Sawa N; Tagami T; Katori H; Takemoto F; Hara S; Takaichi K
Nephron Clin Pract; 2006; 104(1):c15-9. PubMed ID: 16685139
[TBL] [Abstract][Full Text] [Related]
39. [A case of polymyositis complicated with membranous nephritis].
Hara I; Kurata N; Hyozu K; Tamao H
Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):108-9. PubMed ID: 2022901
[No Abstract] [Full Text] [Related]
40. [Extramembranous glomerulonephritis induced by lithium].
Phan L; Coulomb F; Boudon M; Gallois H; Kleinknecht D
Nephrologie; 1991; 12(4):185-7. PubMed ID: 1745336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
